Let's Know Things

By Colin WrightNews News Commentary

Let's Know Things episodes

August 30, 2022 DALL-E 2
This week we talk about OpenAI, AlphaFold, and centaurs.
We also discuss GPT-3, CLIP, and Photoshop.
Show notes / transcript: https://letsknowthings.com/episode327

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
25 min
August 23, 2022 Other Conflicts
This week we talk about Yemen, Syria, and Ethiopia.
We also discuss the Mexican Drug War, Myanmar, and Ukraine.
Show notes / transcript: https://letsknowthings.com/episode326

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
27 min
August 16, 2022 Franchises
This week we talk about Marvel, the Gray Man, and cinematic universes.
We also discuss sequels, remakes, and spin-offs.
Show notes / transcript: https://letsknowthings.com/episode325

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
25 min
August 09, 2022 China's Demographic Crisis
This week we talk about lying flat, letting it rot, and China's Gen Z.
We also discuss replacement rate, the middle class, and baby bonuses.
Show notes / transcript: https://letsknowthings.com/episode324

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
27 min
August 02, 2022 Fleet Electrification
This week we talk about LLVs, NGDVs, and electric school buses.
We also discuss hydrogen, delivery vehicles, and Amazon.
Show notes / transcript: https://letsknowthings.com/episode323

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
28 min
July 26, 2022 CRISPR
This week we talk about CRISPR/cas9, LDL, and human trials.
We also discuss sickle-cell, the human germline, and super-tomatoes.
Show notes / transcript: https://letsknowthings.com/episode322

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
25 min
July 19, 2022 Monkeypox
This week we talk about BA.5, smallpox, and "over there" issues.
We also discuss the WHO, evolving health threats, and prairie dogs.
Show notes / transcript: https://letsknowthings.com/episode321

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
24 min
July 12, 2022 Sunscreen
This week we talk about SPF, UV, and the FDA.
We also discuss oxybenzone, bemotrizinol, and bisoctrizole.
Show notes / transcript: https://letsknowthings.com/episode320

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
24 min
July 05, 2022 Funding Journalism
This week we talk about The Washington Post, Arc XP, and Substack.
We also discuss The New York Times, Axios, and newsletters.
Show notes / transcript: https://letsknowthings.com/episode319

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
33 min
June 28, 2022 Proof-of-Stake
This week we talk about Ethereum, Bitcoin, and The Merge.
We also discuss gas flares, proof-of-work, and regulation.
Show notes / transcript: https://letsknowthings.com/episode318

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit letsknowthings.substack.com/subscribe
22 min

About Let's Know Things

From the publisher's feed

A calm, non-shouty, non-polemical, weekly news analysis podcast for folks of all stripes and leanings who want to know more about what's happening in the world around them. Hosted by analytic…